Third-party lab testing: 4 independent Janoshik assays on file, covering 4 substances, most recent test 2025-08-28.
Tracked by Finnrick with 1 pending/unlisted tests.
QHP is listed as active. Tracked by Finnrick with 1 unlisted tests.
| Substance | Measured purity | Test date |
|---|---|---|
| Tre200mg | not reported | 2025-08-28 |
| Tc250mg | not reported | 2025-08-28 |
| Dp100mg | not reported | 2025-08-28 |
| Nd300mg | not reported | 2025-08-28 |
None of these 4 assays carry a purity number on the certificate. They confirm the substance was submitted and tested, which is not the same as a measured result and not the same as a failure.
| Status | Active |
|---|---|
| Independent assays on file | 4 |
| Vendor type | Research-use supplier |
QHP is listed as active and we hold 4 independent Janoshik assays on file. That is evidence about the batches that were tested or published, not a guarantee about the vial you receive.
Yes. We hold 4 third-party Janoshik assays for QHP, covering 4 substances. The most recent is dated 2025-08-28.
Popular peptides: Semaglutide, Tirzepatide, Retatrutide, BPC-157, CJC-1295, Ipamorelin.
Compare this vendor: Nexaph vs QHP.
Other reviewed vendors: Qianmiao Peptide Review, Qing Li Peptide Review, Qingdao Changlion Peptides Review.